Gender-dependent transthyretin modulation of brain amyloid-β Levels: Evidence from a mouse model of alzheimer's disease

Journal of Alzheimer's Disease

Volumn 27, Issue 2, 2011, Pages 429-439

  Oliveira, Sandra Marisa ^a   Ribeiro, Carlos A ^a   Cardoso, Isabel ^a,b   Saraiva, Maria Joo ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

17 estradiol; Alzheimer's disease; amyloid peptide; testosterone; transgenic mouse; transthyretin

Indexed keywords

AMYLOID BETA PROTEIN; ESTRADIOL; PREALBUMIN; TESTOSTERONE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; FEMALE; GENOTYPE; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; TRANSGENIC MOUSE;

EID: 81855226408     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110488     Document Type: Article

References (50)

1. Goedert M, Spillantini MG (2006) A century of Alzheimer's disease. Science 314, 777-781. (Pubitemid 44706636)
2. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
3. Pimplikar SW, Nixon RA, Robakis NK, Shen J, Tsai LH (2010) Amyloid-independent mechanisms in Alzheimer's disease pathogenesis. J Neurosci 30, 14946-14954.
4. Pike CJ, Carroll JC, Rosario ER, Barron AM (2009) Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol 30, 239-258.
5. Schwarzman AL, Gregori L, Vitek MP, Lyubski S, Strittmat-ter WJ, Enghilde JJ, Bhasin R, Silverman J, Weisgraber KH, Coyle PK et al. (1994) Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci USA 91, 8368-8372. (Pubitemid 24273665)
6. Costa R, Ferreira-da-Silva F, Saraiva MJ, Cardoso I (2008) Transthyretin protects against A-beta peptide toxicity by pro-teolytic cleavage of the peptide: A mechanism sensitive to the Kunitz protease inhibitor. PLoS ONE 3, e2899.
7. Serot JM, Christmann D, Dubost T, Couturier M (1997) Cerebrospinal fluid transthyretin: Aging and late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 63, 506-508. (Pubitemid 27423560)
8. Merched A, Serot JM, Visvikis S, Aguillon D, Faure G, Siest G (1998) Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: Relation with the senile plaques and cytoskeleton biochemistry. FEBS Lett 425, 225-228. (Pubitemid 28178895)
9. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120, 701-713. (Pubitemid 40343081)
10. Choi SH, Leight SN, Lee VM, Li T, Wong PC, Johnson JA, Saraiva MJ, Sisodia SS (2007) Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). J Neurosci 27, 7006-7010. (Pubitemid 47015887)
11. Buxbaum JN, Ye Z, Reixach N, Friske L, Levy C, Das P, Golde T, Masliah E, Roberts AR, Bartfai T (2008) Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci USA 105, 2681-2686. (Pubitemid 351520573)
12. Wati H, Kawarabayashi T, Matsubara E, Kasai A, Hirasawa T, Kubota T, Harigaya Y, Shoji M, Maeda S (2009) Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease. Brain Pathol 19, 48-57.
13. Doggui S, Brouillette J, Chabot JG, Farso M, Quirion R (2010) Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8). Neurodegener Dis 7, 88-95.
14. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland NG, Price DL, Sisodia SS (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945. (Pubitemid 27471397)
15. Wang J, Tanila H, Puolivali J, Kadish I, van Groen T (2003) Gender differences in the amount and deposition of amyloid beta in APPswe and PS1 double transgenic mice. Neurobiol Dis 14, 318-327. (Pubitemid 37543511)
16. Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME, Robertson EJ (1993) Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci US A 90, 2375-2379. (Pubitemid 23078629)
17. Gillies GE, McArthur S (2010) Estrogen actions in the brain and the basis for differential action in men and women: A case for sex-specific medicines. Pharmacol Rev 62, 155-198.
18. Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A (1999) Gender differencesinthe incidenceofADand vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 53, 1992-1997.
19. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D'Agostino RB, White LR (1992) Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 42, 115-119.
20. Brayne C, Gill C, Huppert FA, Barkley C, Gehlhaar E, Girling DM, O'Connor DW, Paykel ES (1995) Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge Project for Later Life. Br J Psychiatry 167, 255-262. (Pubitemid 26194139)
21. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effectsofage, sex, and ethnicityonthe association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA 278, 1349-1356.
22. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, Lobo A, Martinez-Lage J, Soininen H, Hofman A (2000) Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54, S10-S15. (Pubitemid 30390599)
23. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Her-litz A, Winblad B (1997) Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen project, Stockholm. Neurology 48, 132-138. (Pubitemid 27039531)
24. Hagnell O, Ojesjo L, Rorsman B (1992) Incidenceofdementia in the Lundby Study. Neuroepidemiology 11 (Suppl 1), 61-66.
25. Jorm AF, Korten AE, Henderson AS (1987) The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76, 465-479. (Pubitemid 17164786)
26. Letenneur L, Commenges D, Dartigues JF, Barberger-Gateau P (1994) Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol 23, 1256-1261.
27. Molsa PK, Marttila RJ, Rinne UK (1982) Epidemiology of dementia in a Finnish population. Acta Neurol Scand 65, 541-552. (Pubitemid 12085595)
28. Rocca WA, Amaducci LA, Schoenberg BS (1986) Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol 19, 415-424. (Pubitemid 16116475)
29. Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM (2001) Incidence of dementia: Does gender make a difference? Neurobiol Aging 22, 575-580. (Pubitemid 32607742)
30. Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62, 685-691. (Pubitemid 40973444)
31. Buckwalter JG, Sobel E, Dunn ME, Diz MM, Henderson VW (1993) Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. Arch Neurol 50, 757-760. (Pubitemid 23203583)
32. Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H (2004) The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: Modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 1019, 24-28. (Pubitemid 38951278)
33. Henderson VW, Buckwalter JG (1994) Cognitive deficits of men and women with Alzheimer's disease. Neurology 44, 90-96. (Pubitemid 24029436)
34. Morrissette DA, Parachikova A, Green KN, LaFerla FM (2009) Relevance of transgenic mouse models to human Alzheimer disease. J Biol Chem 284, 6033-6037.
35. Callahan MJ, Lipinski WJ, Bian F, Durham RA, Pack A, Walker LC (2001) Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am J Pathol 158, 1173-1177. (Pubitemid 32221809)
36. Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, LaFerla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y (2008) Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 1216, 92-103.
37. Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB (2003) Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci USA 100, 330-335. (Pubitemid 36078074)
38. Butterfield DA, Bush AI (2004) Alzheimer's amyloid beta-peptide (1-42): Involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide. Neurobiol Aging 25, 563-568. (Pubitemid 38686475)
39. Konkle AT, McCarthy MM (2011) Developmental time course of estradiol, testosterone, and dihydrotestosterone levels in discrete regions of male and female rat brain. Endocrinology 152, 223-235.
40. Amtul Z, Wang L, Westaway D, Rozmahel RF (2010) Neu-roprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease. Neuroscience 169, 781-786.
41. Quintela T, Alves CH, Goncalves I, Baltazar G, Saraiva MJ, Santos CR (2008) 5Alpha-dihydrotestosterone up-regulates transthyretin levels in mice and rat choroid plexus via an androgen receptor independent pathway. Brain Res 1229, 18-26.
42. Quintela T, Goncalves I, Baltazar G, Alves CH, Saraiva MJ, Santos CR (2009) 17beta-estradiol induces transthyretin expression inmurine choroid plexus viaanoestrogen receptor dependent pathway. Cell Mol Neurobiol 29, 475-483.
43. Divino CM, Schussler GC (1990) Transthyretin receptors on human astrocytoma cells. J Clin Endocrinol Metab 71, 1265-1268.
44. Divino CM, Schussler GC (1990) Receptor-mediated uptake and internalization of transthyretin. J Biol Chem 265, 1425-1429.
45. Santos SD, Lambertsen KL, Clausen BH, Akinc A, Alvarez R, Finsen B, Saraiva MJ (2010) CSF transthyretin neuropro-tection ina mouse model ofbrain ischemia. J Neurochem 115, 1434-1444.
46. Sousa MM, Norden AG, Jacobsen C, Willnow TE, Chris-tensen EI, Thakker RV, Verroust PJ, Moestrup SK, Saraiva MJ (2000) Evidence for the role of megalin in renal uptake of transthyretin. J Biol Chem 275, 38176-38181. (Pubitemid 32009135)
47. Sousa MM, Saraiva MJ (2001) Internalization of transthy-retin Evidence of a novel yet unidentified receptor-associated protein (RAP)-sensitive receptor. J Biol Chem 276, 14420-14425.
48. Sousa JC, Grandela C, Fernandez-Ruiz J, de Miguel R, de Sousa L, Magalhaes AI, Saraiva MJ, Sousa N, Palha JA (2004) Transthyretin is involved in depression-like behaviour and exploratory activity. J Neurochem 88, 1052-1058. (Pubitemid 38280673)
49. Nunes AF, Saraiva MJ, Sousa MM (2006) Transthyretin knockouts are a new mouse model for increased neuropeptide Y. FASEB J 20, 166-168. (Pubitemid 43100502)
50. Han SH, Jung ES, Sohn JH, Hong HJ, Hong HS, Kim JW, N DL, Kim M, Kim H, Ha HJ, Kim YH, Huh N, Jung MW, Mook-Jung I (2011) Human Serum Transthyretin Levels Correlate Inversely with Alzheimer's Disease. J Alzheimers Dis 25, 77-84.